AIDX 20/20 Biolabs, Inc. - Common Stock
$1,26
Precio · May 20, 2026
Fundamentales a fecha de Mar 31, 2026
Rango 52S
$1–$50
0% of range
Calificación del Analista
—
Precio Objetivo
$5
+297% upside
P/E (TTM)
—
ROE
-503.1%
Margen de Beneficio Neto
-182.8%
AIDX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$1.26
Capitalización Bursátil
—
P/E (TTM)
—
BPA (TTM)
$-0.76
Ingresos (TTM)
$2M
Rendimiento div.
—
ROE
-503.1%
Deuda/Capital
—
Rango 52S
$1 – $50
AIDX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$2M
2024-12-31
→
2025-12-31
BPA
$-0.76
2024-12-31
→
2025-12-31
Flujo de caja libre
—
Márgenes
-182.8%
2025-12-31
→
2025-12-31
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
AIDX
Mediana de Pares
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
AIDX
Mediana de Pares
Gross Margin (Margen Bruto)
29.6%
—
Operating Margin (Margen Operativo)
-162.9%
—
Net Profit Margin (Margen de Beneficio Neto)
-182.8%
—
ROA
-96.8%
—
ROE
-503.1%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
AIDX
Mediana de Pares
Current Ratio (Ratio corriente)
0.6
—
Quick Ratio (Ratio Rápido)
0.5
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
AIDX
Mediana de Pares
Revenue YoY (Ingresos interanuales)
16.7%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
AIDX
Mediana de Pares
AIDX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
Precio objetivo a 12 meses
1 analistas · 2026-05-15
Mín
$5.00
Máx
$5.00
Objetivo mediano
$5.00
+297,0%
Objetivo medio
$5.00
+297,0%
Comparación con pares Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| AIDX | — | — | 16.7% | -182.8% | -503.1% | 29.6% |
| TELA | $53M | -1.4 | 15.8% | -48.4% | -501.1% | 67.7% |
| RMTI | $33M | -5.5 | -31.8% | -7.7% | -15.8% | 16.9% |
| NXGL | — | — | — | — | — | — |
| ADVB | $15M | -4.4 | — | — | -159.1% | — |
| LUCY | — | — | — | — | — | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 15
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue | $2M | $2M | |
| Cost of Revenue | $1M | $1M | |
| Gross Profit | $604.5K | $360.3K | |
| R&D Expense | $592.6K | $1M | |
| SG&A Expense | $3M | $5M | |
| Operating Expenses | $4M | $6M | |
| Operating Income | $-3M | $-6M | |
| Interest Income | $21.4K | $79.5K | |
| Other Non-op | $-115 | $58.9K | |
| Net Income | $-4M | $-6M | |
| EPS (Basic) | $-0.76 | $-1.16 | |
| EPS (Diluted) | $-0.76 | $-1.16 | |
| Shares (Basic) | 4,930,287 | 4,800,524 | |
| Shares (Diluted) | 4,930,287 | 4,800,524 | |
| EBITDA | $-3M | · |
Balance general 22
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $1M | $2M | |
| Receivables | $200.0K | $135.3K | |
| Inventory | $116.2K | $47.2K | |
| Prepaid Expense | $129.0K | $67.8K | |
| Current Assets | $1M | $2M | |
| PP&E (Net) | $56.7K | $116.7K | |
| PP&E (Gross) | $581.2K | $581.2K | |
| Accum. Depreciation | $524.6K | $464.6K | |
| Intangibles | $202.3K | $205.5K | |
| Other Non-current Assets | $23.1K | $162.0K | |
| Total Assets | $4M | $4M | |
| Accounts Payable | $868.5K | $372.3K | |
| Accrued Liabilities | $785.8K | $346.6K | |
| Current Liabilities | $2M | $1M | |
| Capital Leases | $488.7K | $673.8K | |
| Total Liabilities | $4M | $2M | |
| Common Stock | $54.4K | $48.2K | |
| Paid-in Capital | $33M | $31M | |
| Retained Earnings | $-33M | $-30M | |
| Stockholders' Equity | $-19.2K | $2M | |
| Liabilities + Equity | $4M | $4M | |
| Shares Outstanding | 5,442,249 | 4,823,125 |
Flujo de Efectivo 7
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| D&A | $63.3K | $116.0K | |
| Stock-based Comp | $516.2K | $2M | |
| Amort. of Intangibles | $22.5K | $22.5K | |
| Other Non-cash | $1M | · | |
| Operating Cash Flow | $-2M | $-3M | |
| Financing Cash Flow | $1M | $293.3K | |
| Net Change in Cash | $-758.0K | $-2M |
Rentabilidad 6
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Gross Margin | 29.6% | · | |
| Operating Margin | -162.9% | · | |
| Net Margin | -182.8% | · | |
| EBITDA Margin | -159.8% | · | |
| ROA | -96.8% | · | |
| ROE | -503.1% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 0.6 | · | |
| Quick Ratio | 0.5 | · |
Eficiencia 3
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.5 | · | |
| Inventory Turnover | 17.6 | · | |
| Receivables Turnover | 12.2 | · |
Tasas de Crecimiento 1
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | 16.7% | · |
Valoración (TTM) 2
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $2M | · | |
| Net Income TTM | $-4M | · |
Balance general 22
| Métrica | Tendencia | Q4 2025 | Q4 2024 |
|---|---|---|---|
| Cash & Equivalents | $1M | $2M | |
| Receivables | $200.0K | $135.3K | |
| Inventory | $116.2K | $47.2K | |
| Prepaid Expense | $129.0K | $67.8K | |
| Current Assets | $1M | $2M | |
| PP&E (Net) | $56.7K | $116.7K | |
| PP&E (Gross) | $581.2K | $581.2K | |
| Accum. Depreciation | $524.6K | $464.6K | |
| Intangibles | $202.3K | $205.5K | |
| Other Non-current Assets | $23.1K | $162.0K | |
| Total Assets | $4M | $4M | |
| Accounts Payable | $868.5K | $372.3K | |
| Accrued Liabilities | $785.8K | $346.6K | |
| Current Liabilities | $2M | $1M | |
| Capital Leases | $488.7K | $673.8K | |
| Total Liabilities | $4M | $2M | |
| Common Stock | $54.4K | $48.2K | |
| Paid-in Capital | $33M | $31M | |
| Retained Earnings | $-33M | $-30M | |
| Stockholders' Equity | $-19.2K | $2M | |
| Liabilities + Equity | $4M | $4M | |
| Shares Outstanding | 5,442,249 | 4,823,125 |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Ingresos | $2M | $2M |
| Margen Bruto % | 29.6% | — |
| Margen Operativo % | -162.9% | — |
| Beneficio neto | $-4M | $-6M |
| EPS Diluido | $-0.76 | $-1.16 |
Balance general
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Ratio corriente | 0.6 | — |
| Ratio Rápido | 0.5 | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.